Skip to content

Advertisement

Journal of the International Society of Sports Nutrition

Research article
Open Access

Oral L-citrulline supplementation enhances cycling time trial performance in healthy trained men: Double-blind randomized placebo-controlled 2-way crossover study

  • Takashi Suzuki1,
  • Masahiko Morita1,
  • Yoshinori Kobayashi2 and
  • Ayako Kamimura1Email author
Journal of the International Society of Sports Nutrition201613:6

https://doi.org/10.1186/s12970-016-0117-z

©  Suzuki et al. 2016

Received: 11 September 2015

Accepted: 12 February 2016

Published: 19 February 2016

Abstract

Background

Many human studies report that nitric oxide (NO) improves sport performance. This is because NO is a potential modulator of blood flow, muscle energy metabolism, and mitochondrial respiration during exercise. L-Citrulline is an amino acid present in the body and is a potent endogenous precursor of L-arginine, which is a substrate for NO synthase. Here, we investigated the effect of oral L-citrulline supplementation on cycling time trial performance in humans.

Methods

A double-blind randomized placebo-controlled 2-way crossover study was employed. Twenty-two trained males consumed 2.4 g/day of L-citrulline or placebo orally for 7 days. On Day 8 they took 2.4 g of L-citrulline or placebo 1 h before a 4-km cycling time trial. Time taken to complete the 4 km cycle, along with power output/VO2 ratio (PO/VO2), plasma nitrite and nitrate (NOx) and amino acid levels, and visual analog scale (VAS) scores, was evaluated.

Results

L-Citrulline supplementation significantly increased plasma L-arginine levels and reduced completion time by 1.5 % (p < 0.05) compared with placebo. Moreover, L-citrulline significantly improved subjective feelings of muscle fatigue and concentration immediately after exercise.

Conclusions

Oral L-citrulline supplementation reduced the time take to complete a cycle ergometer exercise trial.

Trial registration

Current Controlled Trials UMIN000014278.

Keywords

ErgogenicHumanL-CitrullineNitric oxide (NO)Sport performance

Background

NO plays key roles such as maintaining the function and integrity of the endothelium, including vascular tone and structure [1]. In sports physiology, nitrate supplementation is thought to be an ergogenic aid [2–4]. This view is based on evidence that NO is an important modulator of blood flow and mitochondrial respiration under physiological conditions [5]. Some studies have shown that dietary NO related supplements, such as nitrate-rich beetroot juice, enhance human sport performance [6–9]. Dietary supplementation with nitrate thus appears to be beneficial for exercise.

There is growing interest in the use of L-citrulline as an NO-related dietary ingredient. L-Citrulline is present in the body and is a potent endogenous precursor of L-arginine [10], which is a substrate for NO synthase (NOS). NOS catalyzes a complex enzymatic reaction that leads to NO formation from L-arginine and oxygen and generates L-citrulline as a byproduct [11]. L-Citrulline is effectively recycled via the L-citrulline NO cycle to L-arginine and plays an important role in the metabolism and regulation of NO [12]. L-Citrulline supplementation has various beneficial effects, such as ameliorating arterial stiffness [13] and improving erectile function [14], memory [15], O2 uptake kinetics, and high-intensity exercise performance [16] through upregulation of NO synthesis. We and others have demonstrated in animal models that oral supplementation with L-citrulline upregulates endothelial NO synthase (eNOS) expression, improves endothelial function, and plays an atheroprotective role [17–19]. Interestingly, a clinical trial has shown that oral intake of L-citrulline dose-dependently and more effectively increases plasma L-arginine levels than does L-arginine supplementation in healthy human volunteers [20]. Therefore, L-citrulline may be considered an effective L-arginine and NO supplies which might be expected to have potential for enhancing sport performance. Some studies have found that acute L-citrulline supplementation has no effect on exercise [21, 22]. On the other hand, Bailey et al. [16] showed that 6 days of L-citrulline supplementation improved exercise tolerance. This suggests that chronic L-citrulline supplementation (for about 1 week) is needed to enhance exercise tolerance. However, it is not presently known whether chronic small doses of L-citrulline enhance sport performance. Moreover, to our knowledge, no study has comprehensively evaluated the effects of L-citrulline on endurance exercise performance during simulated competition or on subjective feelings of discomfort associated with exercise in humans. We hypothesized that chronic L-citrulline administration would enhance performance during simulated competition.

The aim of this study was to investigate the effect of oral supplementation of L-citrulline on cycling time-trial performance in healthy trained men.

Methods

Subjects

Twenty-five trained healthy Japanese males volunteered to take part in this double-blind, randomized, placebo-controlled, two-way crossover trial. Because of the crossover design, half of the subjects participated under one condition and half under the other at the same time, with a washout period of 3 weeks. Randomization was conducted by using SAS 9.3 (SAS Institute Inc.). The subjects recruited were aged 20 to 39 years and participated in sport twice a week or more. The sports included athletics (long distance running), baseball, cycling, soccer, triathlon, and skiing. Current smokers, subjects taking medication or dietary supplements for chronic conditions, and subjects with injuries that could interfere with their performance were excluded. The participants’ health status was assessed by both physical and laboratory examinations, including an electrocardiogram and blood chemistry panel. Three males were excluded from the analysis because they had colds on the test day. We therefore analyzed a final total of 22 males (mean ± SD age, 29 ± 8.4 years; body mass, 74 ± 9.4 kg; height, 175 ± 4.1 cm; body mass index, 24 ± 3.3 kg/m2). The subjects were instructed not to change their usual training volume or diet during the 7 days of the study. The protocol was conducted according to the Declaration of Helsinki and was approved by the Ethics Committee of Fukuda Clinic (Osaka, Japan). All subjects gave their written informed consent.

Study design

The study was conducted at Fukuda Clinic (Osaka, Japan). After enrollment, the subjects were randomized into two groups to receive the following treatments once a day for 1 week before the experimental day in a double-blind fashion: 9 capsules consisting of 2.4 g of L-citrulline (KYOWA HAKKO BIO CO., Ltd., Tokyo, Japan) or 9 placebo capsules consisting of 2.4 g of cornstarch (Nippon NSC Co., Ltd., Tokyo, Japan) before bedtime. The indistinguishability of the capsules was confirmed by the Ethics Committee of Fukuda Clinic (Osaka, Japan). The purity of L-citrulline was analyzed by using an amino acid analyzer (L-8900 Hitachi High-Technologies Corporation, Tokyo, Japan) [23, 24]. There is no recommended dose for L-citrulline intake to enhance sport performance, but a dose of 6 or 8 g of L-citrulline malate has been used in other studies [25, 26]. On the day before each test day, subjects were all given the same meals, which they were required to finish by 9:00 PM; they then fasted overnight. The following morning, blood pressure and heart rate were measured and blood samples were collected. Thereafter, the subjects had breakfast (a rice ball, about 180 kcal) to provide energy 1 h before intake of the 9 capsules of placebo or L-citrulline. After the intake of placebo or L-citrulline, the subjects rested quietly before takingpart in a 4-km cycling time trial (TT). Before the TT, each subject completed a warm-up. The TT was performed on a cycle ergometer (Aerobike 75XL2; Konami Sports & Life Co., Ltd., Tokyo, Japan) [27] 1 h after of the intake of placebo or L-citrulline. After the TT, blood samples were collected from the brachial vein. The study design is summarized in Fig. 1.
Fig. 1

Study design

Physical working capacity test

Subjects completed a physical working capacity test to determine work rate during the TT. Physical working capacity is an index employed in performance diagnostics to appraise the tested person’s aerobic performance capacity. The protocol began with 3 min of 25-watt (W) cycling, after which 3 min each of 75-W and 125-W cycling was imposed. Physical working capacity at 75 % of the predicted maximum heart rate (PWC75%HRmax) was determined from the relationship between HR in the final 30 s and exercise work load in the above-mentioned incremental exercise test. PWC75%HRmax was evaluated as work load at 75 % of HRmax (=220 – age) [28]. The subjects were then familiarized with the cycle ergometer.

Time trial test

On Day 8, one hour after intake of 2.4 g of placebo or L-citrulline, each subject performed the TT. The work rate of each subject was set at 60 rpm and PWC75%HRmax. Time to complete 4 km of cycling, power output (PO), VO2, plasma nitrite and nitrate (NOx) levels, plasma amino acid concentrations, and visual analog scale (VAS) scores were evaluated. The computrainer ergometry system recorded PO every 10 s, and these values were averaged for every 0.5 km completed in the TT to create a PO profile. During the TT, breath-by-breath pulmonary gas exchange and ventilation were measured continuously (Aero Monitor AE-300S, Minato Medical Science Co., Ltd., Osaka, Japan) [29–31]. These data were also used to produce a PO/VO2 ratio, namely the PO produced in watts per liter of O2 consumed per min (W/L/min).

Visual analog scale

Subjects were asked to subjectively rate their degree of discomfort on a VAS from 0 mm (excellent) to 100 mm (poor) after the TT. The VAS was originally developed for measuring pain level [32] and has also been used to assess fatigue level [33].

Blood sample analyses

Blood samples were collected from the brachial vein; 5 mL was collected each time. Plasma samples were prepared by collecting blood in an EDTA-2Na-containing tube and kept on ice until centrifugation at 1700 g for 10 min at 4 °C. Plasma NOx was assayed via the Griess reaction by using a colorimetric assay kit (Nitrate/Nitrite Colorimetric Assay Kit, Cayman, Ann Arbor, MI, USA) [34, 35]. To assess amino acids, the plasma sample was deproteinized with 4 % sulfosalicylic acid (plasma to 20 % sulfosalicylic acid ratio = 0.3: 0.075 mL) for 30 min on ice and then centrifuged at 1700 g for 10 min at 4 °C. The supernatant was stored at −80 °C until analysis. The concentrations of amino acids (L-valine, L-isoleucine, L-leucine, L-arginine, and L-citrulline) in the plasma were measured with an amino acid analyzer (L-8900 Hitachi High-Technologies Corporation, Tokyo, Japan) [23, 24].

Statistical analyses

Values are shown as means ± S.E.M. Paired t-tests were used to evaluate the significance of any differences between the placebo and l-citrulline groups. Analyses were performed with SPSS Statistics 22 (IBM Japan, Ltd., Tokyo, Japan). P values of below 0.05 were regarded as statistically significant.

Results

Blood chemistry

Plasma amino acid concentrations are summarized in Table 1. Seven days’ intake of L-citrulline significantly increased the plasma L-arginine level. On Day 8, plasma L-citrulline and L-arginine levels after TT were significantly higher in the l-citrulline group than in the placebo group. Levels of plasma branched chain amino acids (BCAAs: L-valine, L-isoleucine, L-leucine) were significantly lower at pre-load and post-load in the l-citrulline group than in the placebo group. There was no significant difference in the level of plasma NOx between the placebo and L-citrulline groups (Fig. 2).
Table 1

Plasma amino acid concentration on Day 8

 

before TT and before intake

after TT and after intake

 

Placebo

L-Citrulline

Placebo

L-Citrulline

L-Citrulline (nmol/ml)

39.3 ± 1.4

54.3 ± 11.0

40.0 ± 1.4

475 ± 37**

L-Arginine (nmol/ml)

110 ± 4

139 ± 7**

110 ± 4

192 ± 9**

BCAA (nmol/ml) (valine, isoleucine, leucine)

565 ± 15

553 ± 21*

518 ± 20

501 ± 15*

Values are means ± S.E.M. n = 22, * p < 0.05, ** p < 0.001, indicating a significant difference from placebo

Fig. 2

Changes in plasma NOx before and after a 4 km TT. Values are means ± S.E.M. n = 22

Physical performance test

Mean TT completion times are displayed in Fig. 3, and the accompanying PO profiles are shown in Fig. 4a. L-Citrulline supplementation significantly reduced completion time compared with placebo, with a group mean reduction of 1.5 % (placebo: 578 ± 15 s, L-citrulline: 569 ± 14 s, p < 0.05, Fig. 3). Ingestion of L-citrulline increased mean PO by 2 % (placebo = 189 ± 5 W vs. L-citrulline = 193 ± 5 W, p < 0.05, Fig. 4b). There was no significant difference in VO2 response between placebo and L-citrulline (Table 2). PO/VO2 tended to be higher in the L-citrulline-supplemented group in three of six elapsed distances (p < 0.1, Fig. 5).
Fig. 3

Completion times of the 4 km TT after placebo or L-citrulline supplementation. Values are means ± S.E.M. n = 22, * p < 0.05, indicating a significant difference from placebo

Fig. 4

PO profile during the 4 km TT (a) and mean PO (b) of the 4 km TT after placebo or L-citrulline supplementation. Values are means ± S.E.M. n = 22. * p < 0.05, indicating a significant difference from placebo

Table 2

VO2 profile during the 4 km TT

Distance (km)

Placebo

L-Citrulline

VO2 (mL/min)

VO2 (mL/min)

0.0 ~ 0.5

1662 ± 236

1682 ± 255

0.5 ~ 1.0

2396 ± 311

2400 ± 341

1.0 ~ 1.5

2553 ± 319

2539 ± 386

1.5 ~ 2.0

2692 ± 353

2676 ± 381

2.0 ~ 2.5

2777 ± 346

2801 ± 369

2.5 ~ 3.0

2861 ± 344

2847 ± 363

3.0 ~ 3.5

2933 ± 361

2911 ± 377

3.5 ~ 4.0

3005 ± 381

2971 ± 397

Values are means ± S.E.M. n = 22

Fig. 5

PO/VO2 during the 4 km TT after placebo or L-citrulline supplementation. Values are means ± S.E.M. n = 22

Visual analog scale

L-Citrulline significantly improved subjective feelings of muscle fatigue, and concentration, immediately after exercise (Fig. 6). A marked but not statistically significant improvement in ease of pedaling was observed with L-citrulline supplementation (p < 0.1).
Fig. 6

Subjective feelings immediately after exercise. Values are means ± S.E.M. n = 22. * p < 0.05, indicating a significant difference from placebo

Discussion

We demonstrated that oral supplementation with L-citrulline at 2.4 g/day for 7 days significantly increased plasma L-arginine levels. Moreover, intake of L-citrulline for 7 days and I h before the TT significantly increased plasma L-citrulline and L-arginine levels and enhanced cycling TT performance. In addition, subjective feelings of muscle fatigue, and concentration, right after exercise were significantly improved with L-citrulline.

In this human trial, the subjects engaged in TT cycling to allow us to evaluate their exercise performance. Competitive sports typically require athletes to complete a given distance in the shortest possible time. Time-to-exhaustion tests are primarily measures of “exercise capacity,” and because there is no competitive sports event in which competition is based on time and distance before exhaustion, tests of this type have limited physiological validity [36]. It has also been reported that there is no relationship between measured time-to-exhaustion and actual cycling performance [37]. In contrast, the TT protocol used here has a high level of physiological validity [36], provides an accurate simulation of physiological responses during competition [38], and is well correlated with actual race performance [39]. Therefore, L-citrulline intake might be expected to enhance performance in real competitive sport. We used cornstarch as the placebo and the study design was a double-blind crossover; we expected that these factors would reduce the placebo effect.

The improved TT performance after supplementation with L-citrulline was the consequence of significantly greater PO for the same VO2. Interestingly, there was a significant correlation between plasma NOx and PO/VO2 after supplementation with L-citrulline but placebo had no correlation (data not shown). This finding suggests that the effects of L-citrulline on PO/VO2 may have been related to improved plasma NO availability, which in turn may have enhanced sport performance. In sports nutrition, NO-related products are attracting a lot of attention for their ergogenic effects. Many applied studies in humans report that NO improves sports performance. This is because NO is a potential modulator of blood flow, muscle energy metabolism, and mitochondrial respiration during exercise [5, 6, 40, 41]. Dietary supplementation with nitrate reduces the O2 cost of submaximal cycling [6, 42], knee extensor exercise [43], and treadmill walking and running [44]. L-Arginine is the direct precursor of NO via NOS activity. Moreover, oral intake of L-arginine improves sports performance in healthy subjects [45–47]. However, a relatively large dose (6 to 14.2 g/day) of L-arginine would be required for beneficial effects on sports performance, because L-arginine is degraded by arginase in the small intestine and liver [48–50]. For this reason, some studies have shown no effect of L-arginine on O2 cost and sports performance [51, 52]. In contrast, L-citrulline is not metabolized in the intestine or liver [53]. On entering the kidneys, vascular endothelium, and other tissues, L-citrulline is readily converted to L-arginine, thus raising plasma and tissue levels of L-arginine and enhancing NO production [10]. We found here that oral intake of L-citrulline increased not only L-citrulline levels but also L-arginine levels. It has been reported that oral supplementation with L-citrulline increases plasma L-arginine levels more effectively than does L-arginine supplementation in healthy subjects [20], and increased plasma L-arginine levels before exercise enhance sport performance [16]. However, some studies have found that oral L-citrulline supplementation has no effect on exercise [21, 22]. This is likely because a single dose of L-citrulline is insufficient to enhance sport performance. Bailey et al. [16] demonstrated that 6 days of L-citrulline supplementation improved exercise tolerance. These findings suggest that L-citrulline needs to be taken continuously (for about 1 week) to enhance exercise tolerance. This is why we conducted an 8-day trial, which showed positive effects of L-citrulline. The daily dose of L-citrulline in our study was 2.4 g. This seems smaller than those used in other previous studies [16, 21, 22], but 2 to 3 g of oral L-citrulline has been reported to increase plasma L-arginine levels [20, 54]. Moinard et al. [54] showed that the Cmax of plasma L-arginine was 146 μM when subjects consumed 2 g of L-citrulline. In the study by Bailey et al. [16], the L-citrulline group had a mean plasma L-arginine level of 135 μM and showed improved exercise performance. Therefore, we had hypothesized that 2.4 g/day of L-citrulline for 8 days might be enough to increase plasma L-arginine levels such that we would obtain ergogenic effects. In fact, Bailey et al. reported that the plasma L-arginine level in their L-citrulline group was about 2.3 times that in their placebo group [16]. On the other hand, our data demonstrated that the plasma L-arginine level in our L-citrulline group was about 1.7 times that in our placebo group. However, our absolute value of plasma L-arginine after intake of L-citrulline was higher than that in the study by Bailey et al. Therefore, 2.4 g/day of L-citrulline for 8 days is likely enough to obtain ergogenic aid.

We found here that, L-citrulline supplementation significantly increased plasma levels of plasma L-citrulline and L-arginine, which are essential for NO synthesis. In our study the plasma arginine level after supplementation of L-citrulline was as high as that in the study by Bailey et al. [16]. Our results thus suggest that L-citrulline would enhance sport performance through NO synthesis; however, we were not able to observe an increase in plasma NOx level. We measured NOx at only two time points: before and after exercise, not during exercise. These evaluation points might not have been suitable for detecting significant between-point differences in NO generation. Chemiluminescence assay is more sensitive than colorimetric assay for detecting NOx. In this study, we measured NOx by colorimetric assay, and it may not have been sensitive enough to detect changes in plasma NOx.

Sureda et al. [26] showed that oral intake of 6 g of L-citrulline malate 2 h before exercise enhances the use of BCAAs, which are metabolized in the muscles to produce energy. In our study, L-citrulline supplementation decreased plasma BCAA levels. These data indicate that L-citrulline promotes the metabolic use of these amino acids as fuel to support muscular exercise. Moreover, L-citrulline significantly improved subjective feelings of muscular fatigue. BCAA reduces muscle soreness and fatigue [55, 56]. Furthermore, L-citrulline malate reduces fatigue and post-workout muscle soreness [25]; watermelon juice, which is rich in L-citrulline, also reduces muscle soreness [57]. Our data suggest that L-citrulline has the potential to relieve muscle fatigue. Therefore, the effects of L-citrulline on BCAA utilization and muscular fatigue might also contribute to enhanced sport performance. In addition, the subjective feeling of concentration was significantly improved by oral intake of L-citrulline. Hayashi et al. have reported that L-citrulline improves blood flow [17]. The concentration-enhancing effects of L-citrulline are likely due to enhanced blood flow.

A growing number of sport supplements include L-arginine, which is claimed to enhance NO production, despite L-arginine being rapidly metabolized in the small intestine and liver when administered orally. As mentioned above, L-citrulline is a potent precursor of L-arginine, and several functional advantages of L-citrulline over L-arginine have been elucidated [17, 20]; moreover, Akashi et al. [58] have revealed that L-citrulline is an efficient hydroxyl radical scavenger. L-arginine tends to be extremely bitter and highly water absorbent, whereas L-citrulline is tasteless, odorless, and non-hygroscopic. It would thus appear that L-citrulline is superior to L-arginine in terms of ease of handling and taste as an ingredient of supplements. L-Citrulline is present in large quantities in watermelon but is not abundant in other fruits, vegetables, meat, or fish because it is a free amino acid. It is difficult to obtain L-citrulline from a conventional diet in sufficient amounts to enhance sports performance. Therefore, it may be beneficial to take a few tablets of L-citrulline before exercise as an ergogenic aid.

Our study had several limitations. We instructed the subjects not to change their training volumes and to eat their usual diets during the 7 days of the study. However, we did not make the training volumes and diets identical among the subjects, with the exception of dinner on the evening before the test day and breakfast on the test day. Some of the subjects’ performances may have been affected by intense training sessions in the 2 days before the trials. Here, we conducted a double-blind randomized placebo-controlled two-way crossover study in 22 subjects; in future, an additional, larger-scale study will be needed to verify our findings.

Conclusions

We conclude that oral L-citrulline supplementation enhances cycling time trial performance. Moreover, L-citrulline improves subjective feelings (e.g. of muscle soreness) after performance. These data, taken together, suggest that L-citrulline is a promising amino acid for enhancing sport performance.

Abbreviations

BCAAs: 

branched chain amino acids

eNOS: 

endothelial NO synthase

NO: 

nitric oxide

NOS: 

NO synthase

NOx: 

nitrite and nitrate

PO/VO2 : 

power output / VO2 ratio

TT: 

time trial

VAS: 

Visual Analog Scale

Declarations

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Healthcare Products Development Center, KYOWA HAKKO BIO CO., LTD., Tsukuba, Japan
(2)
Laboratory of Pharmacognosy, School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan

References

  1. Albrecht EW, Stegeman CA, Heeringa P, Henning RH, Van Goor H. Protective role of endothelial nitric oxide synthase. J Pathol. 2003;199:8–17.View ArticlePubMedGoogle Scholar
  2. Petroczi A, Naughton DP. Potentially fatal new trend in performance enhancement: a cautionary note on nitrite. J Int Soc Sports Nutr. 2010;7:25.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Bescos R, Sureda A, Tur JA, Pons A. The effect of nitric-oxide-related supplements on human performance. Sports Med. 2012;42:99–117.View ArticlePubMedGoogle Scholar
  4. Jones AM. Dietary nitrate supplementation and exercise performance. Sports Med. 2014;44 Suppl 1:S35–45.View ArticlePubMedGoogle Scholar
  5. Shen W, Xu X, Ochoa M, Zhao G, Wolin MS, Hintze TH. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res. 1994;75:1086–95.View ArticlePubMedGoogle Scholar
  6. Bailey SJ, Winyard P, Vanhatalo A, Blackwell JR, Dimenna FJ, Wilkerson DP, et al. Dietary nitrate supplementation reduces the O2 cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans. J Appl Physiol (1985). 2009;107:1144–55.View ArticleGoogle Scholar
  7. Cermak NM, Gibala MJ, van Loon LJ. Nitrate supplementation’s improvement of 10-km time-trial performance in trained cyclists. Int J Sport Nutr Exerc Metab. 2012;22:64–71.PubMedGoogle Scholar
  8. Lansley KE, Winyard PG, Bailey SJ, Vanhatalo A, Wilkerson DP, Blackwell JR, et al. Acute dietary nitrate supplementation improves cycling time trial performance. Med Sci Sports Exerc. 2011;43:1125–31.View ArticlePubMedGoogle Scholar
  9. Wilkerson DP, Hayward GM, Bailey SJ, Vanhatalo A, Blackwell JR, Jones AM. Influence of acute dietary nitrate supplementation on 50 mile time trial performance in well-trained cyclists. Eur J Appl Physiol. 2012;112:4127–34.View ArticlePubMedGoogle Scholar
  10. Curis E, Nicolis I, Moinard C, Osowska S, Zerrouk N, Benazeth S, et al. Almost all about citrulline in mammals. Amino Acids. 2005;29:177–205.View ArticlePubMedGoogle Scholar
  11. Schmidt HH, Nau H, Wittfoht W, Gerlach J, Prescher KE, Klein MM, et al. Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur J Pharmacol. 1988;154:213–6.View ArticlePubMedGoogle Scholar
  12. Hecker M, Sessa WC, Harris HJ, Anggard EE, Vane JR. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. Proc Natl Acad Sci U S A. 1990;87:8612–6.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Ochiai M, Hayashi T, Morita M, Ina K, Maeda M, Watanabe F, et al. Short-term effects of L-citrulline supplementation on arterial stiffness in middle-aged men. Int J Cardiol. 2012;155:257–61.View ArticlePubMedGoogle Scholar
  14. Hotta Y, Shiota A, Kataoka T, Motonari M, Maeda Y, Morita M, et al. Oral L-citrulline supplementation improves erectile function and penile structure in castrated rats. Int J Urol. 2014;21:608–12.View ArticlePubMedGoogle Scholar
  15. Yabuki Y, Shioda N, Yamamoto Y, Shigano M, Kumagai K, Morita M, et al. Oral L-citrulline administration improves memory deficits following transient brain ischemia through cerebrovascular protection. Brain Res. 2013;1520:157–67.View ArticlePubMedGoogle Scholar
  16. Bailey SJ, Blackwell JR, Lord T, Vanhatalo A, Winyard PG, Jones AM. L-citrulline supplementation improves O2 uptake kinetics and high-intensity exercise performance in humans. J Appl Physiol (1985). 2015;19(4):385–95. doi:10.1152/japplphysiol.00192.2014.View ArticleGoogle Scholar
  17. Hayashi T, Juliet PA, Matsui-Hirai H, Miyazaki A, Fukatsu A, Funami J, et al. l-Citrulline and l-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits. Proc Natl Acad Sci U S A. 2005;102:13681–6.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Romero MJ, Platt DH, Tawfik HE, Labazi M, El-Remessy AB, Bartoli M, et al. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res. 2008;102:95–102.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Wu G, Collins JK, Perkins-Veazie P, Siddiq M, Dolan KD, Kelly KA, et al. Dietary supplementation with watermelon pomace juice enhances arginine availability and ameliorates the metabolic syndrome in Zucker diabetic fatty rats. J Nutr. 2007;137:2680–5.PubMedGoogle Scholar
  20. Schwedhelm E, Maas R, Freese R, Jung D, Lukacs Z, Jambrecina A, et al. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol. 2008;65:51–9.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Cutrufello PT, Gadomski SJ, Zavorsky GS. The effect of l-citrulline and watermelon juice supplementation on anaerobic and aerobic exercise performance. J Sports Sci. 2015;33:1459–66.View ArticlePubMedGoogle Scholar
  22. Hickner RC, Tanner CJ, Evans CA, Clark PD, Haddock A, Fortune C, et al. L-citrulline reduces time to exhaustion and insulin response to a graded exercise test. Med Sci Sports Exerc. 2006;38:660–6.View ArticlePubMedGoogle Scholar
  23. Heo KN, Hong EC, Kim CD, Kim HK, Lee MJ, Choo HJ, et al. Growth performance, carcass yield, and quality and chemical traits of meat from commercial korean native ducks with 2-way crossbreeding. Asian-Australas J Anim Sci. 2015;28:382–90.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Watts ST. Advancements in Amino Acid Analysis: Introduction of the New Hitachi L-8900 Amino Acid Analyzer. LCGC N Am. 2006;24(Suppl):17–20.Google Scholar
  25. Perez-Guisado J, Jakeman PM. Citrulline malate enhances athletic anaerobic performance and relieves muscle soreness. J Strength Cond Res. 2010;24:1215–22.View ArticlePubMedGoogle Scholar
  26. Sureda A, Cordova A, Ferrer MD, Perez G, Tur JA, Pons A. L-citrulline-malate influence over branched chain amino acid utilization during exercise. Eur J Appl Physiol. 2010;110:341–51.View ArticlePubMedGoogle Scholar
  27. Sugino T, Aoyagi S, Shirai T, Kajimoto Y, Kajimoto O. Effects of citric acid and l-carnitine on physical fatigue. J Clin Biochem Nutr. 2007;41:224–30.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Nagashima J, Musha H, Takada H, Takagi K, Mita T, Mochida T, et al. Three-month exercise and weight loss program improves heart rate recovery in obese persons along with cardiopulmonary function. J Cardiol. 2010;56:79–84.View ArticlePubMedGoogle Scholar
  29. Abe T, Fujita S, Nakajima T, Sakamaki M, Ozaki H, Ogasawara R, et al. Effects of Low-intensity cycle training with restricted Leg blood flow on thigh muscle volume and VO2MAX in young Men. J Sports Sci Med. 2010;9:452–8.PubMedPubMed CentralGoogle Scholar
  30. Nagai N, Sakane N, Tsuzaki K, Moritani T. UCP1 genetic polymorphism (−3826 A/G) diminishes resting energy expenditure and thermoregulatory sympathetic nervous system activity in young females. Int J Obes (Lond). 2011;35:1050–5.View ArticleGoogle Scholar
  31. Yamada K, Suda T, Komoro YS, Kanefuji T, Kubota T, Murayama T, et al. Low fat intake is associated with pathological manifestations and poor recovery in patients with hepatocellular carcinoma. Nutr J. 2013;12:79.View ArticlePubMedPubMed CentralGoogle Scholar
  32. Maxwell C. Sensitivity and accuracy of the visual analogue scale: a psycho-physical classroom experiment. Br J Clin Pharmacol. 1978;6:15–24.View ArticlePubMedPubMed CentralGoogle Scholar
  33. Leung AW, Chan CC, Lee AH, Lam KW. Visual analogue scale correlates of musculoskeletal fatigue. Percept Mot Skills. 2004;99:235–46.PubMedGoogle Scholar
  34. Mayo JN, Beard Jr RS, Price TO, Chen CH, Erickson MA, Ercal N, et al. Nitrative stress in cerebral endothelium is mediated by mGluR5 in hyperhomocysteinemia. J Cereb Blood Flow Metab. 2012;32:825–34.View ArticlePubMedPubMed CentralGoogle Scholar
  35. Tuzcu H, Aslan I, Aslan M. The effect of high-dose insulin analog initiation therapy on lipid peroxidation products and oxidative stress markers in type 2 diabetic patients. Oxid Med Cell Longev. 2013;2013:513742.View ArticlePubMedPubMed CentralGoogle Scholar
  36. Currell K, Jeukendrup AE. Validity, reliability and sensitivity of measures of sporting performance. Sports Med. 2008;38:297–316.View ArticlePubMedGoogle Scholar
  37. Laursen PB, Rhodes EC, Langill RH, McKenzie DC, Taunton JE. Relationship of exercise test variables to cycling performance in an Ironman triathlon. Eur J Appl Physiol. 2002;87:433–40.View ArticlePubMedGoogle Scholar
  38. Foster C, Green MA, Snyder AC, Thompson NN. Physiological responses during simulated competition. Med Sci Sports Exerc. 1993;25:877–82.View ArticlePubMedGoogle Scholar
  39. Palmer GS, Dennis SC, Noakes TD, Hawley JA. Assessment of the reproducibility of performance testing on an air-braked cycle ergometer. Int J Sports Med. 1996;17:293–8.View ArticlePubMedGoogle Scholar
  40. Tschakovsky ME, Joyner MJ. Nitric oxide and muscle blood flow in exercise. Appl Physiol Nutr Metab. 2008;33:151–61.View ArticlePubMedGoogle Scholar
  41. Larsen FJ, Schiffer TA, Borniquel S, Sahlin K, Ekblom B, Lundberg JO, et al. Dietary inorganic nitrate improves mitochondrial efficiency in humans. Cell Metab. 2011;13:149–59.View ArticlePubMedGoogle Scholar
  42. Larsen FJ, Weitzberg E, Lundberg JO, Ekblom B. Effects of dietary nitrate on oxygen cost during exercise. Acta Physiol (Oxf). 2007;191:59–66.View ArticleGoogle Scholar
  43. Bailey SJ, Fulford J, Vanhatalo A, Winyard PG, Blackwell JR, DiMenna FJ, et al. Dietary nitrate supplementation enhances muscle contractile efficiency during knee-extensor exercise in humans. J Appl Physiol (1985). 2010;109:135–48.View ArticleGoogle Scholar
  44. Lansley KE, Winyard PG, Fulford J, Vanhatalo A, Bailey SJ, Blackwell JR, et al. Dietary nitrate supplementation reduces the O2 cost of walking and running: a placebo-controlled study. J Appl Physiol (1985). 2011;110:591–600.View ArticleGoogle Scholar
  45. Campbell B, Roberts M, Kerksick C, Wilborn C, Marcello B, Taylor L, et al. Pharmacokinetics, safety, and effects on exercise performance of L-arginine alpha-ketoglutarate in trained adult men. Nutrition. 2006;22:872–81.View ArticlePubMedGoogle Scholar
  46. Fricke O, Baecker N, Heer M, Tutlewski B, Schoenau E. The effect of L-arginine administration on muscle force and power in postmenopausal women. Clin Physiol Funct Imaging. 2008;28:307–11.View ArticlePubMedGoogle Scholar
  47. Koppo K, Taes YE, Pottier A, Boone J, Bouckaert J, Derave W. Dietary arginine supplementation speeds pulmonary VO2 kinetics during cycle exercise. Med Sci Sports Exerc. 2009;41:1626–32.View ArticlePubMedGoogle Scholar
  48. Hayashi T, Esaki T, Sumi D, Mukherjee T, Iguchi A, Chaudhuri G. Modulating role of estradiol on arginase II expression in hyperlipidemic rabbits as an atheroprotective mechanism. Proc Natl Acad Sci U S A. 2006;103:10485–90.View ArticlePubMedPubMed CentralGoogle Scholar
  49. Munder M. Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol. 2009;158:638–51.View ArticlePubMedPubMed CentralGoogle Scholar
  50. Castillo L, Chapman TE, Sanchez M, Yu YM, Burke JF, Ajami AM, et al. Plasma arginine and citrulline kinetics in adults given adequate and arginine-free diets. Proc Natl Acad Sci U S A. 1993;90:7749–53.View ArticlePubMedPubMed CentralGoogle Scholar
  51. Alvares TS, Conte CA, Paschoalin VM, Silva JT, Meirelles Cde M, Bhambhani YN, et al. Acute l-arginine supplementation increases muscle blood volume but not strength performance. Appl Physiol Nutr Metab. 2012;37:115–26.View ArticlePubMedGoogle Scholar
  52. Vanhatalo A, Bailey SJ, DiMenna FJ, Blackwell JR, Wallis GA, Jones AM. No effect of acute L-arginine supplementation on O(2) cost or exercise tolerance. Eur J Appl Physiol. 2013;113:1805–19.View ArticlePubMedGoogle Scholar
  53. Romero MJ, Platt DH, Caldwell RB, Caldwell RW. Therapeutic use of citrulline in cardiovascular disease. Cardiovasc Drug Rev. 2006;24:275–90.View ArticlePubMedGoogle Scholar
  54. Moinard C, Nicolis I, Neveux N, Darquy S, Benazeth S, Cynober L. Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study. Br J Nutr. 2008;99:855–62.View ArticlePubMedGoogle Scholar
  55. Kim DH, Kim SH, Jeong WS, Lee HY. Effect of BCAA intake during endurance exercises on fatigue substances, muscle damage substances, and energy metabolism substances. J Exerc Nutrition Biochem. 2013;17:169–80.View ArticlePubMedPubMed CentralGoogle Scholar
  56. Matsumoto K, Koba T, Hamada K, Sakurai M, Higuchi T, Miyata H. Branched-chain amino acid supplementation attenuates muscle soreness, muscle damage and inflammation during an intensive training program.J Sports Med Phys Fitness. 2009;49:424–31.PubMedGoogle Scholar
  57. Tarazona-Diaz MP, Alacid F, Carrasco M, Martinez I, Aguayo E. Watermelon juice: potential functional drink for sore muscle relief in athletes. J Agric Food Chem. 2013;61:7522–8.View ArticlePubMedGoogle Scholar
  58. Akashi K, Miyake C, Yokota A. Citrulline, a novel compatible solute in drought-tolerant wild watermelon leaves, is an efficient hydroxyl radical scavenger. FEBS Lett. 2001;508:438–42.View ArticlePubMedGoogle Scholar

Copyright

© Suzuki et al. 2016

Advertisement

Journal of the International Society of Sports Nutrition

ISSN: 1550-2783

Contact us